Table 3.
Measures of Cardiac Function
| CMR1 Functional Measures | N=28 |
|---|---|
| CMR LVEF2 (%) | 51 ± 9.3 (33–66) |
| CMR indexed LVEDV3 (ml/m2) | 66 ± 14 (42–104) |
| CMR indexed LVESV4 (ml/m2) | 33 ± 12 (17–70) |
| CMR RVEF5 (%) | 54 ± 5.3 (42–66) |
| Late gadolinium enhancement (N=25) | 19 (76%) |
| CMR εcc6 (%) | −14.1 ± 3.3 (−7.8–−20.1) |
| Median Days between CMR and Echocardiogram | 0 (0–22) |
| Mean Echocardiographic Functional Measures | |
| M-mode FS7 (%) | 27.0 ± 5.3 |
| 2-Dimensional FS (%) | 26.5 ± 6.1 |
| Biplane LVEF (%) | 51.1 ± 5.4 |
| 4 chamber LVEF (%) | 47.7 ± 7.4 |
| 5/6 area-length LVEF (%) | 50.8 ± 8.4 |
| 3-Dimensional LVEF (%) | 44.5 ± 10.2 |
| Echocardiographic εcc (%) | −16.2 ± 4.4 (−5.1–−23.0) |
1
Cardiac magnetic resonance imaging (CMR)
2
Left ventricular ejection fraction (LVEF)
3
Left ventricular end diastolic volume (LVEDV)
4
Left ventricular end systolic volume (LVESV)
5
Right ventricular ejection fraction (RVEF)
6
Circumferential strain (εcc)
7
Fractional shortening (FS)